HPV Vaccine Still Effective with Fewer Than Three Doses

Share this content:
The HPV-16/18 vaccine appears to protect against the viral strain even after one or two doses.
The HPV-16/18 vaccine appears to protect against the viral strain even after one or two doses.

The human papillomavirus (HPV)-16/18 vaccine appears to protect against the viral strain even after one or two doses, according to a combined post-hoc analysis published online this week in the journal The Lancet Oncology.

The post-hoc analysis is a combination of the Costa Rica Vaccine Trial and the PATRICIA trial. These two phase 3, double-blind trials evaluated the efficacy of different HPV-16/18 vaccine doses and the researchers randomly assigned women aged 15-25 years to receive three (n=22,327), two (n=1,185), or one (n=543) doses.

After four years of follow-up, the efficacy of the three doses of HPV-16/18 vaccine was 77.0% (95% CI: 74.7, 79.1), two doses was 76.0% (95% CI: 62.0, 85.3), and one dose was 85.7% (95% CI: 70.7, 93.7).

Furthermore, vaccine efficacy for women who received two-dose regimen was 75% (95% CI: 54.2, 87.5) and 82.6% (95% CI: 42.3, 96.1) when they received the second dose at 1 month and 6 months, respectively.

RELATED: Many Students Mistakenly Believe HPV Risk is Low

However, HPV-31/33/45 vaccine efficacy seems to vary with dosage regimen where three doses was 59.7% (95% CI: 56.0, 63.0), two doses was 37.7% (95% CI: 12.4, 55.9), and one dose was 36.6% (95% CI: –5.4, 62.2).

The findings suggest that the HPV-16/18 vaccine seems to protect against the virus from fewer than three-dose schedule, and there was cross-protection when the administration time for two doses was separated by six months.

Reference

  1. Kreimer AR, Struyf F, Del Rosario-Raymundo MR, et al. Efficacy of fewer than three doses of an HPV-1618 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA trial. Lancet Oncol. 2015. [Epub ahead of print]. doi: 10.1016/S1470-2045(15)00047-9.

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters